As analysts unveil their top stock picks for 2020, it’s also worth examining how their top picks for 2019 ended up performing. Today’s article does just that, identifying the top 20 Wall Street picks for 2019 among large-cap, mid-cap and small-cap stocks (based on the number of “buy” or equivalent analyst ratings and implied upside potential at the beginning of the year) and their total returns through mid-December. How did analysts’ stock selections do – and how does this analysis “shed light on one of the problems with Wall Street”? CLICK HERE.
Investors may be wary of health care stocks heading into an election year where the future of health care in the U.S. will be hotly debated – and drug companies are likely to be the targets of heated rhetoric on both sides. However, Goldman Sachs believes that any changes will be “evolutionary rather than revolutionary” – and its strategists have identified three health care stocks set to outperform next year. For these three stocks, CLICK HERE.
Many articles and books have been written – and movies made – telling stories from the 2008 financial crisis – from those who lost everything to those who made a fortune. However, the author of today’s article states that “there’s an incredible story from 2008 that few people know.” He proceeds to tell that story — about how investors could have made a killing by buying one of the world’s biggest financial companies during the financial crisis — and highlights its lesson for investors about a type of stock that “can deliver huge returns during any kind of market.” CLICK HERE.
“Investors should always regard the stock market as sailors regard the sea — a means to an end, usually benign, but potentially lethal.” The author of today’s article cites this quote in reminding that, while it may seem that we are in “a new era of endless investment prosperity” where there is little need to fear the bear, recessions are normal and are to be expected — and while bear markets can actually be a welcome development for younger investors, “older investors should take the prospect of a bear market seriously. Very seriously.” For his eight steps to prepare for the bear, CLICK HERE.
With approximately 100 new biotech companies having begun trading on the Nasdaq exchange since the beginning of last year alone, the author of today’s article observes that “There are so many new biotech stocks hitting the market that plenty of gems slip through the cracks unnoticed” – and he goes on to highlight two of them. For these two under-the-radar biotechs – one of which has developed a potential new treatment for depression while the other “is taking advantage of gravity to develop a blindness prevention drug that lasts longer than the competition” – CLICK HERE.
The hottest stock-market sector may also be the best investment opportunity right now, both in terms of long-term returns and short-term gains. We’re talking about utilities! Why are utility stocks good investments today? What are the top utility dividend stocks? What do investors need to be aware of with the utility industry going through a period of mergers and acquisitions? And what should investors look at when considering utilities to buy? For more, CLICK HERE.
You’ve identified and bought a stock that you believe is undervalued. Now, the critical question becomes how long do you wait for that undervalued stock to recover to fair value and reward you? Noting that “the unfortunate truth is that the required timeframe often can or will try the investor’s patience beyond what they can tolerate”, the author of today’s article attempts to establish some expectations – and offers several examples illustrating how undervalued stocks can still reward investors even before recovering to fair value. For more, CLICK HERE.
They are not as rare as their name suggests, but a rare opportunity may be setting up in so-called rare-earth minerals as China considers weaponizing the metals (for which it is responsible for 90% of global production) as part of the ongoing trade war and cutting off export of them to the U.S. Specifically, this opportunity involves investing in non-Chinese rare earth producers, which could benefit from such action by China. For more – including details on the rare earth producers operating in the U.S., Australia and Canada – CLICK HERE.
“Even as the stock market hits new highs, there’s discernible negativity toward the technology sector,” notes the author of today’s article. But is this negativity misplaced? He proceeds to outline how much of the negativity surrounding the tech sector currently is based on “false fears”, making the space an attractive buy. Additionally, a number of experts with strong track records in the tech sector name their favorite picks at the moment, including what one top-performing portfolio manager declares “is the best place in tech to be invested.” For more, CLICK HERE.
The S&P 500 could soon hit a new high – and keep on going from there, according to company analysts who see the benchmark gaining 7% over the next year. Which stocks do company analysts see leading the S&P’s march higher (including a biopharmaceutical stock that could double over the next 12 months) – and which stocks might be poised to suffer the biggest losses over the same period? CLICK HERE.